Zscaler, Inc. (ZS) Stock Analysis
Is ZS a good investment?
Zscaler, Inc. (ZS) has a Plutrex AI rating of 74.0/100 as of October 08, 2026, indicating a Buy consensus. The stock is not classified as halal-compliant. Key strength: Investor Day guidance reaffirmation eliminates the go-to-market execution risk from the CRO departure: CFO explicitly reaffirmed Q1 and full-year FY2027 guidance, eight analyst firms raised price targets, and the $8-10B long-term ARR roadmap provides a credible growth narrative — analyst consensus target jumped 14.5% from $209.92 to $240.40, validating improved confidence. Main concern: Structural forward EPS growth deficit vs. peers remains fully UNCHANGED: ZS at 14.8% next-year and 16.1% 5-year EPS growth trails the Software-Infrastructure industry average of 22.7%/23.1% by ~32-35%, meaning ZS cannot justify a valuation premium versus peers — with P/B now at 13.40x (up from 12.11x), any quarterly EPS miss risks meaningful multiple compression.
Investment Summary
Zscaler (ZS) at $213.55 is a high-quality cybersecurity platform with exceptional unit economics (76.4% gross margin, $852M FCF) but trades at a significant premium after a 10.6% price increase since our last report 11 days ago. The analyst consensus target has jumped from $209.92 to $240.40 (+14.5%), reflecting post-Investor Day enthusiasm where management reaffirmed Q1 and full-year FY2027 guidance and laid out a path to $8-10B ARR. Eight analyst firms raised price targets. However, the structural concern from our prior report remains fully intact: ZS's forward EPS growth of 14.8% (next year) and 16.1% (5-year) continues to trail the Software-Infrastructure industry average of 22.7%/23.1% by ~32-35%. The stock now offers 12.6% upside to the new $240.40 consensus target — improved from the prior 8.7% — but that upside is entirely offset by the stock having risen 10.6% to prices where the margin of safety is thin. The CRO departure risk has meaningfully eased following a successful Investor Day with guidance reaffirmation. Net assessment: Hold for existing positions; new buyers should wait for the $203-$210 entry zone that represents a more defensible risk/reward.
Key Strengths
- Investor Day guidance reaffirmation eliminates the go-to-market execution risk from the CRO departure: CFO explicitly reaffirmed Q1 and full-year FY2027 guidance, eight analyst firms raised price targets, and the $8-10B long-term ARR roadmap provides a credible growth narrative — analyst consensus target jumped 14.5% from $209.92 to $240.40, validating improved confidence
- Best-in-class unit economics: 76.4% gross margin (+12.1pp vs. industry average 64.2%) and $852M annual FCF (~30%+ FCF margin) confirm a self-funding business model with substantial operating leverage potential as growth investment moderates — $3.47B cash provides multi-year strategic runway
- AI security monetization opens new TAM: IBM Lightwell collaboration combining Zscaler Autonomous Application Shield, CEO commentary on AI agent security ('don't trust them'), and prior period's 50% AI bookings jump signal Zscaler is capturing emerging AI security spend that could drive forward EPS estimate revisions above the current 14.8-16.1% consensus
Key Concerns
- Structural forward EPS growth deficit vs. peers remains fully UNCHANGED: ZS at 14.8% next-year and 16.1% 5-year EPS growth trails the Software-Infrastructure industry average of 22.7%/23.1% by ~32-35%, meaning ZS cannot justify a valuation premium versus peers — with P/B now at 13.40x (up from 12.11x), any quarterly EPS miss risks meaningful multiple compression
- Margin of safety is thin after the 10.6% price surge: At $213.55 vs. prior entry midpoint of $187.50, the stock has moved well past our prior entry zone — the 12.6% upside to the new $240.40 analyst target provides insufficient cushion given GAAP losses (operating margin -1.0%, net margin -1.9%), P/B of 13.40x with ROE of -2.9%, and the Jefferies note flagging the $10B ARR target as 'ambitious'
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
ZS presents the classic high-growth SaaS dichotomy. Gross margin of 76.4% (vs. industry average 64.2%, +12.1pp premium) is best-in-class and confirms exceptional unit economics. FCF of $852M implies ~30%+ FCF margins on ~$2.8B revenue — real cash generation that validates the business despite GAAP losses. Operating margin of -1.0% (vs. industry +34.2%) and net margin of -1.9% (vs. industry +29.1%) reflect aggressive growth investment funded by stock-based compensation. P/E and PEG ratios are incalculable due to GAAP losses, forcing valuation onto P/B of 13.40x (up from 12.11x prior period) — a premium that requires sustained execution. Revenue growth of 24.9% YoY is essentially at parity with the industry average of 26.6%. D/E of 0.69 is modestly above the industry's 0.52, partially offset by $3.47B cash fortress. The key forward growth metrics — 14.8% next-year EPS growth and 16.1% 5-year EPS growth — remain ~32-35% below industry peers, which is THE central valuation constraint. Historical EPS growth of 29.3% YoY provides upside optionality if management's $8-10B ARR targets prove achievable. Additional metrics: ROE: -2.9%
News Sentiment
Zscaler is riding a wave of Wall Street enthusiasm after a blockbuster Investor Day that laid out the cybersecurity company's ambitious roadmap to dominate the AI security era. The headline: eight analyst firms raised their price targets, with Wall Street now projecting 29% upside for the stock — a dramatic shift from just weeks ago when a key executive departure had rattled investors. At the heart of the story is Zscaler's bold claim that it can grow its annual recurring revenue from roughly $2.5 billion today to $8-10 billion over the long term. CEO Jay Chaudhry made headlines with a memorable soundbite on AI security: 'The best way to secure AI agents is don't trust them' — a nod to the company's core Zero Trust philosophy now being extended to the AI era. The company also unveiled a new partnership with IBM, combining Zscaler's Autonomous Application Shield with IBM's Lightwell platform to tackle AI-driven security threats. CFO reaffirmation of both Q1 and full-year fiscal 2027 guidance at Investor Day sent a clear message: management is confident in near-term execution. Not everyone is convinced, though — Jefferies characterized the $10 billion ARR target as 'ambitious,' a reminder that the growth path requires sustained execution in a competitive market. For everyday investors, the bottom line is that Zscaler has successfully reset its narrative from 'executive departure concerns' to 'AI security leader with a credible long-term plan' — but the stock has already moved 10% to reflect much of that good news.
Risk Assessment
PRIMARY RISK: Valuation compression from growth deficit. ZS's 32-35% forward EPS growth lag vs. peers (14.8% vs 22.7% next year; 16.1% vs 23.1% five-year) means any quarterly execution miss or macro headwind could trigger a de-rating of the 13.40x P/B multiple. At $213.55 with no GAAP earnings, the stock is priced for perfection. SECONDARY RISK: $10B ARR target flagged as 'ambitious' by Jefferies — if management's long-term roadmap is viewed as a stretch, near-term disappointments on ARR trajectory could compress the stock materially. MITIGATING FACTORS: $3.47B cash eliminates liquidity risk; $852M FCF means the business is self-funding; guidance reaffirmation at Investor Day removes near-term earnings surprise risk; AI security tailwind (IBM collaboration, Autonomous Application Shield) could drive estimate revisions higher. STOP LOGIC: $188 represents ~12% below current price, aligns with prior breakout zone support, and limits loss to approximately $18.50/share from entry midpoint of $206.50 — defensible for a quality cybersecurity compounder.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is ZS a halal stock?
No, Zscaler, Inc. (ZS) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for ZS?
Zscaler, Inc. (ZS) has a Plutrex AI rating of 74.0/100 with a Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is ZS a good investment?
According to Plutrex AI, ZS has a Buy rating (74.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in ZS?
US stocks like ZS can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in ZS?
Plutrex AI identifies the main risks for ZS by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.